Linked Data API

Show Search Form

Search Results

1150840
unstar this property registered interest false more like this
star this property date less than 2019-10-21more like thismore than 2019-10-21
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he has had with the Department of Health, Social Services and Public Safety in Northern Ireland on the introduction of HPV Primary Screening in Northern Ireland. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 2728 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-28more like thismore than 2019-10-28
star this property answer text <p>The Secretary of State for Health and Social Care has not had any direct discussion with the Department of Health in Northern Ireland on the introduction of human papillomavirus (HPV) primary screening in this jurisdiction.</p><p>The Northern Ireland Screening Committee has agreed a programme of work to be led by the Northern Ireland Public Health Agency during 2019/20 to inform the development of a policy paper on introducing HPV testing in Northern Ireland cervical screening for consideration by the Department of Health in Northern Ireland in 2020.</p><p> </p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 2729 more like this
star this property question first answered
less than 2019-10-28T15:52:12.53Zmore like thismore than 2019-10-28T15:52:12.53Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1150841
unstar this property registered interest false more like this
star this property date less than 2019-10-21more like thismore than 2019-10-21
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential merits of the introduction of HPV primary screening in Northern Ireland. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 2729 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-28more like thismore than 2019-10-28
star this property answer text <p>The Secretary of State for Health and Social Care has not had any direct discussion with the Department of Health in Northern Ireland on the introduction of human papillomavirus (HPV) primary screening in this jurisdiction.</p><p>The Northern Ireland Screening Committee has agreed a programme of work to be led by the Northern Ireland Public Health Agency during 2019/20 to inform the development of a policy paper on introducing HPV testing in Northern Ireland cervical screening for consideration by the Department of Health in Northern Ireland in 2020.</p><p> </p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 2728 more like this
star this property question first answered
less than 2019-10-28T15:52:12.593Zmore like thismore than 2019-10-28T15:52:12.593Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1137416
unstar this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list (a) the criteria and (b) the timelines for products to be considered in (i) the current and (ii) future review rounds of the Accelerated Access Collaborative. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 274540 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-15T15:23:36.753Zmore like thismore than 2019-07-15T15:23:36.753Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1137418
unstar this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what criteria the Accelerated Access Collaborative uses in relation to decision-making on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 274542 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in supporting the most strategically important products that will have the biggest impact on patient health outcomes and delivery of National Health Service services.</p><p>When selecting products, the AAC will consider the following irrespective of innovation type (i.e. medicines, diagnostic tools, and digital products):</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p>Further information is available at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p><p> </p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-15T15:33:03.587Zmore like thismore than 2019-07-15T15:33:03.587Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1134018
unstar this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list the (a) criteria and (b) timelines for products to be considered in (i) the current round and (ii) future review rounds of the Accelerated Access Collaborative route. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268506 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:12:14.213Zmore like thismore than 2019-07-02T16:12:14.213Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1134019
unstar this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how products selected by the Accelerated Access Collaborative will be funded. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268507 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>As announced in the Life Sciences Sector Deal 2, up to £2 million of Pathway Transformation Funding has been made available to support the use and integration of product selected by the Accelerated Access Collaborative (AAC) into every day practice within the National Health Service. In addition, four of the seven technology areas currently receiving AAC support have been selected to be funded by NHS England through the Innovation and Technology Payment programme (ITP). The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:07:33.677Zmore like thismore than 2019-07-02T16:07:33.677Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1134020
unstar this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether all products considered by the Accelerated Access Collaborative will have to be cost-neutral to the NHS. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268508 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>As it continues to drive forward the assessment and uptake of the best products for support, the Accelerated Access Collaborative (AAC) has been empowered to be flexible and pragmatic enough to identify truly game-changing innovations, that may not be cost-neutral in year, but are assessed by the National Institute for Health and Care Excellence to be both clinically and cost-effective. This will allow the AAC to identify products, or classes of products, that are most likely to significantly transform care in the National Health Service.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:06:04.58Zmore like thismore than 2019-07-02T16:06:04.58Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1134021
unstar this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268509 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:12:48.417Zmore like thismore than 2019-07-02T16:12:48.417Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1134022
unstar this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how the Accelerated Access Collaborative plans to balance its focus on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268510 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>There are no restrictions on the type of innovation that can be supported by the Accelerated Access Collaborative (AAC). Medicinal products, therapeutic technologies, devices, diagnostics, and digital technologies are eligible to receive support.</p><p>In October 2018, the AAC announced it was supporting to increased uptake and use of 12 high performing products, which span seven technology areas, in the National Health Service. Of the seven categories selected for support, two are medicines, four are diagnostic tests, and one is a device.</p><p>Further information about the products the AAC are supporting can be found at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:06:55.223Zmore like thismore than 2019-07-02T16:06:55.223Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter
1149985
unstar this property registered interest false more like this
star this property date less than 2019-10-16more like thismore than 2019-10-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Addictions: Health Services more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what programmes are in place to support people with addictions. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 1036 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-25more like thismore than 2019-10-25
star this property answer text <p>The Government takes the issues of addiction seriously and recognises the harms they can cause to an individual and those around them. Anyone concerned about an addiction should initially approach their general practitioner for advice. Local authorities are responsible for assessing the needs of their local population and commissioning services to meet these needs, including commissioning services to support people to recover from alcohol and drug dependence. We are supporting them in this through the provision of data, guidance and targeted support and funding via the Public Health Grant. The public health grant will increase in real terms in 2020/21. This means local authorities can continue to invest in prevention and essential frontline health services.</p><p> </p><p> </p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-10-25T12:53:48.913Zmore like thismore than 2019-10-25T12:53:48.913Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon remove filter